Dr. Llamusí co-founded Arthex in December 2019 and is CSO of the company. During the initial steps of the project that led to Arthex foundation, she was granted different competitive acceleration programs (FIPS and Caixaimpulse) to assess the feasibility of the entrepreneurial project, including training in business management and development, IPP, financial and regulatory issues. She holds an MSc and Ph.D. in Biochemistry from the University Miguel Hernández. During her Ph.D. program, she focused on the molecular bases of neuronal regeneration, and subsequently worked in the Department of Genetics as a postdoctoral researcher. She has dedicated more than 13 years investigating the pathogenic mechanisms of rare neuromuscular diseases and approaches to treatment. During this period, she produced more than 30 scientific articles and seven patents.